Your browser doesn't support javascript.
loading
Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53-Mutated Metastatic Colorectal Cancer.
Lahoz, Sara; Rodríguez, Adela; Fernández, Laia; Gorría, Teresa; Moreno, Reinaldo; Esposito, Francis; Oliveres, Helena; Albiol, Santiago; Saurí, Tamara; Pesantez, David; Riu, Gisela; Cuatrecasas, Miriam; Jares, Pedro; Pedrosa, Leire; Pineda, Estela; Postigo, Antonio; Castells, Antoni; Prat, Aleix; Maurel, Joan; Camps, Jordi.
Afiliação
  • Lahoz S; Gastrointestinal and Pancreatic Oncology Team, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic of Barcelona, Consorcio de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, 08036 Barcelona, Spain.
  • Rodríguez A; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Fernández L; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Gorría T; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Moreno R; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Esposito F; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Oliveres H; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Albiol S; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Saurí T; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Pesantez D; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Riu G; Pharmacology Department, Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
  • Cuatrecasas M; Gastrointestinal and Pancreatic Oncology Team, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic of Barcelona, Consorcio de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, 08036 Barcelona, Spain.
  • Jares P; Pathology Department, Centro de Diagnóstico Biomédico, Molecular Biology CORE, Hospital Clínic, Tumor Bank-Biobank, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Pedrosa L; Pathology Department, Centro de Diagnóstico Biomédico, Molecular Biology CORE, Hospital Clínic, Tumor Bank-Biobank, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Pineda E; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Postigo A; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
  • Castells A; Group of Transcriptional Regulation of Gene Expression, IDIBAPS, Department of Biomedicine, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
  • Prat A; ICREA, 08010 Barcelona, Spain.
  • Maurel J; Gastrointestinal and Pancreatic Oncology Team, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic of Barcelona, Consorcio de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, 08036 Barcelona, Spain.
  • Camps J; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
Cancers (Basel) ; 14(23)2022 Nov 30.
Article em En | MEDLINE | ID: mdl-36497403
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article